Radius Health, Inc. (RDUS)
USD 29.43
(0.14%)
USD 29.43
(0.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 359.28 Million USD | 9.51% |
| 2022 | 328.07 Million USD | 80.54% |
| 2021 | 181.71 Million USD | -14.1% |
| 2020 | 211.53 Million USD | -2.39% |
| 2019 | 216.72 Million USD | -27.18% |
| 2018 | 297.62 Million USD | 63.39% |
| 2017 | 182.15 Million USD | 170.45% |
| 2016 | -258.56 Million USD | -61.93% |
| 2015 | -159.67 Million USD | -319.84% |
| 2014 | 72.63 Million USD | 10246.72% |
| 2013 | 702 Thousand USD | -67.38% |
| 2012 | 2.15 Million USD | 116.11% |
| 2011 | -13.36 Million USD | -17505.24% |
| 2010 | 76.77 Thousand USD | 76870.0% |
| 2009 | -100.00 USD | 99.9% |
| 2008 | -100 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 464.82 Million USD | 12.74% |
| 2023 Q1 | 412.29 Million USD | -12.86% |
| 2023 Q4 | 394.7 Million USD | 9.86% |
| 2023 Q3 | 359.28 Million USD | -22.71% |
| 2023 FY | 359.28 Million USD | 9.51% |
| 2022 Q1 | 268.52 Million USD | 17.7% |
| 2022 Q3 | 328.07 Million USD | 22.45% |
| 2022 Q4 | 473.11 Million USD | 44.21% |
| 2022 FY | 328.07 Million USD | 80.54% |
| 2022 Q2 | 267.91 Million USD | -0.23% |
| 2021 Q2 | 240.12 Million USD | 4.97% |
| 2021 Q4 | 228.13 Million USD | -0.75% |
| 2021 Q3 | 229.85 Million USD | -4.27% |
| 2021 Q1 | 228.76 Million USD | 357.19% |
| 2021 FY | 181.71 Million USD | -14.1% |
| 2020 FY | 211.53 Million USD | -2.39% |
| 2020 Q2 | 227.51 Million USD | -14.58% |
| 2020 Q3 | 143.27 Million USD | -37.03% |
| 2020 Q4 | -88.94 Million USD | -162.08% |
| 2020 Q1 | 266.35 Million USD | 22.9% |
| 2019 Q3 | 181.77 Million USD | -24.92% |
| 2019 Q2 | 242.1 Million USD | -1.07% |
| 2019 Q4 | 216.72 Million USD | 19.23% |
| 2019 Q1 | 244.73 Million USD | -17.77% |
| 2019 FY | 216.72 Million USD | -27.18% |
| 2018 Q3 | 286.28 Million USD | -4.88% |
| 2018 FY | 297.62 Million USD | 63.39% |
| 2018 Q1 | 292.64 Million USD | 60.66% |
| 2018 Q2 | 300.96 Million USD | 2.84% |
| 2018 Q4 | 297.62 Million USD | 3.96% |
| 2017 Q2 | -135.11 Million USD | 22.63% |
| 2017 Q1 | -174.62 Million USD | 32.47% |
| 2017 FY | 182.15 Million USD | 170.45% |
| 2017 Q4 | 182.15 Million USD | 169.25% |
| 2017 Q3 | -263.03 Million USD | -94.68% |
| 2016 FY | -258.56 Million USD | -61.93% |
| 2016 Q1 | -104.41 Million USD | 34.61% |
| 2016 Q4 | -258.56 Million USD | -30.22% |
| 2016 Q3 | -198.56 Million USD | -64.71% |
| 2016 Q2 | -120.55 Million USD | -15.46% |
| 2015 Q4 | -159.67 Million USD | 5.33% |
| 2015 Q3 | -168.67 Million USD | -750.16% |
| 2015 FY | -159.67 Million USD | -319.84% |
| 2015 Q1 | -10.34 Million USD | -114.25% |
| 2015 Q2 | -19.84 Million USD | -91.73% |
| 2014 Q3 | 7.85 Million USD | 204.73% |
| 2014 Q2 | 2.57 Million USD | 113.29% |
| 2014 Q1 | -19.39 Million USD | -2863.11% |
| 2014 FY | 72.63 Million USD | 10246.72% |
| 2014 Q4 | 72.63 Million USD | 824.57% |
| 2013 Q1 | 5.54 Million USD | 157.62% |
| 2013 Q3 | -4.28 Million USD | 44.62% |
| 2013 Q4 | 702 Thousand USD | 116.38% |
| 2013 FY | 702 Thousand USD | -67.38% |
| 2013 Q2 | -7.74 Million USD | -239.63% |
| 2012 Q2 | 4.08 Million USD | 161.9% |
| 2012 Q3 | 1.57 Million USD | -61.51% |
| 2012 Q4 | 2.15 Million USD | 36.81% |
| 2012 FY | 2.15 Million USD | 116.11% |
| 2012 Q1 | -6.6 Million USD | 50.58% |
| 2011 Q4 | -13.36 Million USD | 5.54% |
| 2011 Q3 | -14.14 Million USD | 27.86% |
| 2011 Q2 | -19.6 Million USD | -22504.02% |
| 2011 Q1 | 87.52 Thousand USD | 14.0% |
| 2011 FY | -13.36 Million USD | -17505.24% |
| 2010 Q2 | -100.00 USD | -100.0% |
| 2010 FY | 76.77 Thousand USD | 76870.0% |
| 2010 Q4 | 76.77 Thousand USD | 76870.0% |
| 2010 Q3 | -100.00 USD | 0.0% |
| 2010 Q1 | 6.49 Million USD | 6500000.0% |
| 2009 Q3 | -100.00 USD | 0.0% |
| 2009 Q2 | -100.00 USD | -100.0% |
| 2009 Q1 | 6.24 Million USD | 6349.9% |
| 2009 FY | -100.00 USD | 99.9% |
| 2009 Q4 | -100.00 USD | 0.0% |
| 2008 Q4 | -100 Thousand USD | -103.31% |
| 2008 Q2 | -2.51 Million USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | -100 Thousand USD | 0.0% |
| 2008 Q3 | 3.02 Million USD | 220.09% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 458.69 Million USD | 21.674% |
| Theratechnologies Inc. | 24.87 Million USD | -1344.578% |
| Safety Shot Inc | -2.28 Million USD | 15827.759% |
| Cosmos Health Inc. | 8.59 Million USD | -4082.181% |
| Cronos Group Inc. | -663.32 Million USD | 154.164% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 42.366% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 2565.557% |
| Organogenesis Holdings Inc. | 15.01 Million USD | -2293.133% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -182082.862% |
| ProPhase Labs, Inc. | 19.23 Million USD | -1768.239% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 14357.183% |
| Dynavax Technologies Corporation | 106.63 Million USD | -236.926% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 3910.087% |
| Alvotech | 1.06 Billion USD | 66.243% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 2397.98% |
| Alpha Teknova, Inc. | 1.97 Million USD | -18100.659% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 374.619% |
| SCYNEXIS, Inc. | -19.35 Million USD | 1956.749% |
| Harrow Health, Inc. | 116.41 Million USD | -208.616% |
| Biofrontera Inc. | 4.05 Million USD | -8758.013% |
| DURECT Corporation | -7.65 Million USD | 4794.029% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 1171.617% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | -281.374% |
| OptiNose, Inc. | 58.06 Million USD | -518.757% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 7027.861% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | -379.361% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -336119.691% |
| SIGA Technologies, Inc. | -148.68 Million USD | 341.644% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | -194.739% |
| Shineco, Inc. | 29.29 Million USD | -1126.621% |
| Phibro Animal Health Corporation | 454.84 Million USD | 21.01% |
| Procaps Group S.A. | 242.93 Million USD | -47.894% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -9668.38% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 12482.902% |
| Viatris Inc. | 17.13 Billion USD | 97.903% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 2397.98% |
| Rockwell Medical, Inc. | 4.45 Million USD | -7962.859% |
| Incannex Healthcare Limited | -5.48 Million USD | 6650.246% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 7466.844% |
| Tilray Brands, Inc. | 158.97 Million USD | -125.996% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 17.47% |
| PetIQ, Inc. | 351.93 Million USD | -2.088% |
| Silver Spike Investment Corp. | -32.61 Million USD | 1201.696% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | -102.64% |
| Journey Medical Corporation | -9.7 Million USD | 3800.494% |
| Alimera Sciences, Inc. | 55.3 Million USD | -549.589% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 7199.876% |
| Assertio Holdings, Inc. | -32.52 Million USD | 1204.494% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 24233.519% |
| Embecta Corp. | 1.31 Billion USD | 72.616% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 4474.286% |
| Procaps Group, S.A. | 242.93 Million USD | -47.894% |
| PainReform Ltd. | -7.95 Million USD | 4619.258% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | -8419.825% |
| Hempacco Co., Inc. | 13.61 Million USD | -2538.924% |
| Talphera, Inc. | -5.72 Million USD | 6380.038% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 16.976% |
| Alvotech | 1.06 Billion USD | 66.243% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 471.503% |
| Kamada Ltd. | -46.43 Million USD | 873.787% |
| Indivior PLC | -33.95 Million USD | 1158.203% |
| Currenc Group, Inc. | -16.57 Million USD | 2267.853% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -137780.602% |
| Flora Growth Corp. | -713 Thousand USD | 50490.042% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 4474.286% |
| Evolus, Inc. | 63.7 Million USD | -463.95% |
| HUTCHMED (China) Limited | -197.45 Million USD | 281.953% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 25.011% |
| Akanda Corp. | 3.9 Million USD | -9100.736% |